Clinical Trials Browser

Interventional × Small Cell Lung Carcinoma × vistusertib × Clear all

NCT03366103 2023-10-17

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Phase 1/2 Terminated

15 enrolled 14 charts

Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT03106155 2018-09-20

[SUKSES-D]

Phase 2 Terminated

Small Cell Lung Carcinoma